Compare Enseval Putera Megatrading Tbk. (EPMT) vs Medela Potentia Tbk. (MDLA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enseval Putera Megatrading Tbk. vs Medela Potentia Tbk. — how do they compare? Enseval Putera Megatrading Tbk. trades at Rp2,330 (market cap 6.23T, 3.1K 24h volume), while Medela Potentia Tbk. trades at Rp206 (market cap 2.91T, 383.3K 24h volume). The key difference: Enseval Putera Megatrading Tbk. is far larger — about 2.1× Medela Potentia Tbk.'s market cap, and Medela Potentia Tbk. is more actively traded (383.3K versus 3.1K). Which is the better fit depends on your goals.
| EPMT | MDLA | |
|---|---|---|
Market Cap | 6.23T | 2.91T |
Volume | 3.1K | 383.3K |
Lot | 31 | 3.83K |
Turnover | 7.21M | 79.26M |
Average Price | 2,325.48 | 206.79 |
Value | 7.21M | 79.26M |
Indicative Equilibrium Price | — | 206 |
Indicative Equilibrium Volume | — | 150 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enseval Putera Megatrading Tbk.
PT. Enseval Putera Megatrading Tbk, formerly PT Arya Gupta Cempaka, was established based on deed No. 64 dated October 26, 1998 of Mrs. Rukmasanti Hardjasatya,SH, notary public in Jakarta. The company’s articles of association have been amended several times, most recently by deed No. 200 dated June 30, 1997 of Mrs. Poerbaningsih Adi Warsito, SH, notary public in Jakarta, concerning the changes of the company’s articles of association to comply with Corporate Law no. 1 year 1995, the increase in the company’s authorized capital and the change in par value per share from Rp 1,000 to Rp 500.
Read more on EPMT →About Medela Potentia Tbk.
PT Medela Potentia Tbk. (Company) was established based on Deed of Establishment No. 04 dated August 5, 2011, of Public Notary Evy Ferdiana, S.H, Notary of Bekasi Regency, domiciled in Lemah Abang. The Company started its operation activities in 2013.
Read more on MDLA →
